Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC
Condition: Breast Cancer Interventions: Drug: Ribociclib; Other: Mono-chemotherapy; Other: Endocrine-Therapy Sponsors: Swiss Group for Clinical Cancer Research; The Belgian Society of Medical Oncology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials